Concepedia

Huan-Chang Liang

HL

Statistics

Publications

5

Citations

230

H-Index

5

Active since

2018

Affiliations

Medical University of Vienna(Current)

University of Cambridge

German Cancer Research Center

University of Veterinary Medicine Vienna

Heidelberg University

Huan-Chang Liang is an author at Medical University of Vienna specializing in molecular oncology, oncology, and lymphoma pathogenesis.

ORCID

Publications per year

2018–2022

5

Publications

5

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma

Nikolai Schleußner, Olaf Merkel, Mariantonia Costanza et al. · Leukemia · 2018 · 89 citations · Full text

, , +14

Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma

Nicole Prutsch, Elisabeth Gurnhofer, Tobias Suske et al. · Leukemia · 2018 · 54 citations · Full text

, , +17

Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma

Huan-Chang Liang, Mariantonia Costanza, Nicole Prutsch et al. · Nature Communications · 2021 · 45 citations · Full text

, , +16

IL10RA Modulates Crizotinib Sensitivity in NPM1-ALK-positive Anaplastic Large Cell Lymphoma

Nina Prokoph, Nicola Anna Probst, Liam Changwoo Lee et al. · Blood · 2020 · 30 citations · Full text

, , +12

CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL

Ivonne A. Montes‐Mojarro, Julia Steinhilber, Christoph M. Griessinger et al. · Leukemia · 2022 · 12 citations · Full text

, , +17

1–5 of 5